To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose Combination

NCT05737771 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

FDC
Diabetes Mellitus, Type 2

Interventions

DRUG: DWC202213
DRUG: DWJ1563
DRUG: DWP16001

Sponsor

Daewoong Pharmaceutical Co. LTD.